Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie E Combs

Showing results (331-340 of 567) with videos related to

Pageof 57
Sort By:
World Journal of Surgical Oncology|April 19, 2015
Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinomaDaniel Habermehl, Ingo C Brecht, Frank Bergmann, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2014
Four-dimensional patient dose reconstruction for scanned ion beam therapy of moving liver tumorsDaniel Richter, Nami Saito, Naved Chaudhri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2021
Detection efficacy of <sup>18</sup>F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatmentIsabel Rauscher, Amir Karimzadeh, Kilian Schiller, et al.
Radiation Oncology (London, England)|January 5, 2017
Risk of second cancer following radiotherapy for prostate cancer: a population-based analysisNina-Sophie Hegemann, Anne Schlesinger-Raab, Ute Ganswindt, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2008
Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimensStephanie E Combs, Johanna Wagner, Marc Bischof, et al.
Neuro-Oncology|August 6, 2013
Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylationWolfgang Wick, Joachim P Steinbach, Michael Platten, et al.
Radiation Oncology (London, England)|March 29, 2018
Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanningRami A El Shafie, Maja Czech, Kerstin A Kessel, et al.
Radiation Oncology (London, England)|May 10, 2018
Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningiomaRami A El Shafie, Maja Czech, Kerstin A Kessel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 7, 2015
Clinical implementation and range evaluation of in vivo PET dosimetry for particle irradiation in patients with primary gliomaSebastian P Nischwitz, Julia Bauer, Thomas Welzel, et al.
Frontiers in Oncology|August 16, 2021
Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy <i>Versus</i> Conventional Salvage Radiotherapy for Patients With Recurrent Prostate CancerMarco M E Vogel, Sabrina Dewes, Eva K Sage, et al.
Pageof 57

Showing results (331-340 of 567) with videos related to

Sort By:
Pageof 57
World Journal of Surgical Oncology|April 19, 2015
Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinomaDaniel Habermehl, Ingo C Brecht, Frank Bergmann, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2014
Four-dimensional patient dose reconstruction for scanned ion beam therapy of moving liver tumorsDaniel Richter, Nami Saito, Naved Chaudhri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2021
Detection efficacy of <sup>18</sup>F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatmentIsabel Rauscher, Amir Karimzadeh, Kilian Schiller, et al.
Radiation Oncology (London, England)|January 5, 2017
Risk of second cancer following radiotherapy for prostate cancer: a population-based analysisNina-Sophie Hegemann, Anne Schlesinger-Raab, Ute Ganswindt, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2008
Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimensStephanie E Combs, Johanna Wagner, Marc Bischof, et al.
Neuro-Oncology|August 6, 2013
Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylationWolfgang Wick, Joachim P Steinbach, Michael Platten, et al.
Radiation Oncology (London, England)|March 29, 2018
Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanningRami A El Shafie, Maja Czech, Kerstin A Kessel, et al.
Radiation Oncology (London, England)|May 10, 2018
Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningiomaRami A El Shafie, Maja Czech, Kerstin A Kessel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 7, 2015
Clinical implementation and range evaluation of in vivo PET dosimetry for particle irradiation in patients with primary gliomaSebastian P Nischwitz, Julia Bauer, Thomas Welzel, et al.
Frontiers in Oncology|August 16, 2021
Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy <i>Versus</i> Conventional Salvage Radiotherapy for Patients With Recurrent Prostate CancerMarco M E Vogel, Sabrina Dewes, Eva K Sage, et al.
Pageof 57